The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nurofen Long Lasting 300 mg prolonged-release tablets



Reckitt Benckiser Ireland LtdPA0979/081/001

Main Information

Trade NameNurofen Long Lasting 300 mg prolonged-release tablets
Active SubstancesIbuprofen
Dosage FormProlonged-release tablet
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/081/001

Group Information

ATC CodeM01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued12/05/2023
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct is not subject to medical prescription, subject to the following conditions: Max. Daily dose 1200mg Max. Pack size: 25
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back